YAP regulates HER3 signaling-driven adaptive resistance to RET inhibitors in RET-aberrant cancer.
Katayama Y, Yamada T, Tanimura K, Kawachi H, Ishida M, Matsui Y, Hirai S, Nakamura R, Morimoto K, Furuya N, Arai S, Goto Y, Sakata Y, Nishino K, Tsuchiya M, Tamiya A, Saito G, Muto S, Takeda T, Date K, Fujisaka Y, Watanabe S, Fujimoto D, Uehara H, Horinaka M, Sakai T, Yano S, Tokuda S, Takayama K.
Katayama Y, et al. Among authors: tsuchiya m.
Clin Cancer Res. 2024 Nov 4. doi: 10.1158/1078-0432.CCR-24-1762. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 39495173